Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · April 15, 2024

Genetic and T2 Biomarkers Linked to the Efficacy of HDM Sublingual Immunotherapy in Patients With Asthma

Thorax

 

Additional Info

Thorax
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma
Thorax 2024 Mar 15;79(4)332-339, I Hoof, K Bønnelykke, T Stranzl, S Brand, X Li, MH Shamji, DA Meyers, ED Bateman, E Bleecker, PS Andersen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading